This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
ADSTILADRIN
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
ECLIPSE
ESCAPE
FORT
NRG-GU 0101
Masofaniten (EPI-7386)
METANOVA
RTIRE
SHORTER
Right Side
PCCTC
DORA
IRONMAN
PROMISE
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SESAUA 2024
Southern CA GU Cancer Research Forum 2024
AUA Urology Advocacy Summit 2024
ASCO GU 2024
2024 UCSF-UCLA PSMA Conference
SUO 2023
All Conferences
View All
PCF
UroToday Home
Conference Highlights
ASCO GU 2021
Penile, Urethral, Testicular, and Adrenal Cancers
ASCO GU 2021
Prostate Cancer
Bladder Cancer
Kidney Cancer
Penile, Urethral, Testicular, and Adrenal Cancers
Press Releases
ASCO GU 2021 Penile, Urethral, Testicular, and Adrenal Cancers
Viewing 1-20 of 10957 articles
Advanced Prostate Cancer Consensus Conference (APCCC) 2024 Scientific Programme
SESAUA 2024: Time Interval Between Radium-223 Therapy and 177Lu-PSMA Treatment for mCRPC and Outcomes in the RALU Study
SESAUA 2024: State of the Art Lecture: Management of Complications Following RPLND
SESAUA 2024: Addressing Racial Disparities in Prostate Cancer Prediction Models: External Validation and Comparison of Four Models of Pathological Outcome Prediction before Radical Prostatectomy
SESAUA 2024: Screening with PSA and MRI: Yearly Trends by PI-RADS and Race Shows Stable Diagnosis of NCCN Very Low Risk Disease
SESAUA 2024: Darolutamide in Combination with ADT and Docetaxel: Efficacy and Safety by Disease Volume and Risk in the Phase 3 ARASENS Trial
SESAUA 2024: Association of PSA Response and Overall Survival in Patients with mHSPC: Results from the Phase 3 ARASENS Trial
SESAUA 2024: Should I Order a PET Scan? Integrating Molecular Imaging into Urologic Oncology Clinical Practice: Current Approaches and Future Opportunities
SESAUA 2024: Non-Narcotic Compliance and Clinical Outcomes in ERAS Cystectomy Patients
SESAUA 2024: Skeletal Muscle Changes in Upper Tract Urothelial Carcinoma Following Radical Nephroureterectomy
SESAUA 2024: Safety and Efficacy of Surgery in Metastatic and Non-Metastatic RCC with Supradiaphragmatic Tumor Thrombus Involving Cardiac Procedures
SESAUA 2024: Prognostic Significance of Pathologic Response to Neoadjuvant Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder with Variant Histology
SESAUA 2024: Determining the Genetic Causes of Bladder Cancer in a Family with Heritable Pattern of Bladder Cancer
SESAUA 2024: State of the Art Lecture: Digital Discounts for Urology Patients: Online Tools to Decrease Out-of-Pocket Prescription Costs
SESAUA 2024: Intravascular Heparinization During IVC Thrombectomy and Perioperative Complications
SESAUA 2024: Prevalence, Trends, and Costs of Office-Based and ASC-Based Diagnostic Cystoscopy in the United States
SESAUA 2024: Darolutamide, Enzalutamide, and Apalutamide for Non-Metastatic Castration-Resistance Prostate Cancer Patients in the United States (DEAR): Comparative Real-World Evidence
SESAUA 2024: Investigating the Role of Access to Quality Care for Muscle-Invasive Bladder Cancer in the Disparate Outcomes Among Sociodemographically Disadvantaged Patients in the State of Kentucky
SESAUA 2024: Impact of Rural Location on Receipt of Standard of Care Treatment and Survival for Locally Advanced Bladder Cancer in Louisiana
SESAUA 2024: Feasibility and Outcomes of Interventions to Reduce Cystoscopy Discomfort: A Quality Improvement Project
1
2
3
4
5
6
7
8
9
10
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free